Small molecule compositions and methods for increasing drug efficiency using compositions thereof

Details for Australian Patent Application No. 2004275770 (hide)

Owner Dihedron Corporation

Inventors Castellino, Angelo John; Ballatore, Carlo; Newman, Michael James; Wirsching, Peter; Sun, Chengzao; Desharnais, Joel; Aspland, Simon Eric

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004275770

PCT Pub. Number WO2005/030258

Priority 60/505,325 22.09.03 US; 60/581,835 22.06.04 US

Filing date 22 September 2004

Wipo publication date 7 April 2005

International Classifications

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/475 (2006.01) - having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

A61K 31/704 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 49/04 (2006.01) Preparations for testing - X-ray contrast preparations

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/030258 Priority application(s): WO2005/030258

10 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004275771-Iloprost in combination therapies for the treatment of pulmonary arterial hypertension

2004275764-High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products